|
1
|
Martin TA, Watkins G, Mansel RE and Jiang
WG: Loss of tight junction plaque molecules in breast cancer
tissues is associated with a poor prognosis in patients with breast
cancer. Eur J Cancer. 40:2717–2725. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martin TA, Mansel RE and Jiang WG:
Antagonistic effect of NK4 on HGF/SF induced changes in the
transendothelial resistance (TER) and paracellular permeability of
human vascular endothelial cells. J Cell Physiol. 192:268–275.
2002. View Article : Google Scholar
|
|
3
|
Ren J, Hamada J, Takeichi N, Fujikawa S
and Kobayashi H: Ultrastructural differences in junctional
intercellular communication between highly and weakly metastatic
clones derived from rat mammary carcinoma. Cancer Res. 50:358–362.
1990.
|
|
4
|
Satoh H, Zhong Y, Isomura H, et al:
Localization of 7H6 tight junction-associated antigen along the
cell border of vascular endothelial cells correlates with
paracellular barrier function against ions, large molecules, and
cancer cells. Exp Cell Res. 222:269–274. 1996. View Article : Google Scholar
|
|
5
|
Hoevel T, Macek R, Mundigl O, Swisshelm K
and Kubbies M: Expression and targeting of the tight junction
protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell
Physiol. 191:60–68. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kominsky SL, Argani P, Korz D, et al: Loss
of the tight junction protein claudin-7 correlates with
histological grade in both ductal carcinoma in situ and invasive
ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krämer F, White K, Kubbies M, Swisshelm K
and Weber BH: Genomic organization of claudin-1 and its assessment
in hereditary and sporadic breast cancer. Hum Genet. 7:249–256.
2002.PubMed/NCBI
|
|
8
|
Chlenski A, Ketels KV, Korovaitseva GI,
Talamonti MS, Oyasu R and Scarpelli DG: Organization and expression
of the human zo-2 gene (tjp-2) in normal and neoplastic tissues.
Biochim Biophys Acta. 1493:319–324. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bell J, Walsh S, Nusrat A and Cohen C:
Zonula occludens-1 and Her-2/neu expression in invasive breast
carcinoma. Appl Immunohistochem Mol Morphol. 11:125–129. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martin TA, Watkins G, Mansel RE and Jiang
WG: Hepatocyte growth factor disrupts tight junctions in human
breast cancer cells. Cell Biol Int. 28:361–371. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ikenouchi J, Matsuda M, Furuse M and
Tsukita S: Regulation of tight junctions during the
epithelium-mesenchyme transition: direct repression of the gene
expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar
|
|
12
|
Martin TA, Goyal A, Watkins G and Jiang
WG: Expression of the transcription factors snail, slug, and twist
and their clinical significance in human breast cancer. Ann Surg
Oncol. 12:488–496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohkubo T and Ozawa M: The transcription
factor Snail downregulates the tight junction components
independently of E-cadherin downregulation. J Cell Sci.
117:1675–1685. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gopalakrishnan S, Raman N, Atkinson SJ and
Marrs JA: Rho GTPase signaling regulates tight junction assembly
and protects tight junctions during ATP depletion. Am J Physiol.
275:C798–C809. 1998.PubMed/NCBI
|
|
15
|
Wong V and Gumbiner BM: A synthetic
peptide corresponding to the extracellular domain of occludin
perturbs the tight junction permeability barrier. J Cell Biol.
136:399–409. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krajewska M, Olson AH, Mercola D, Reed JC
and Krajewski S: Claudin-1 immunohistochemistry for distinguishing
malignant from benign epithelial lesions of prostate. Prostate.
67:907–910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hewitt KJ, Agarwal R and Morin PJ: The
claudin gene family: expression in normal and neoplastic tissues.
BMC Cancer. 6:1862006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng JY, Yu D, Foroohar M, Ko E, Chan J,
Kim N, Chiu R and Pang S: Regulation of the expression of the
prostate-specific antigen by claudin-7. J Membr Biol. 194:187–197.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Long H, Crean CD, Lee WH, Cummings OW and
Gabig TG: Expression of Clostridium perfringens enterotoxin
receptors claudin-3 and claudin-4 in prostate cancer epithelium.
Cancer Res. 61:7878–7881. 2001.
|
|
20
|
Meyer HW, Freytag C, Freytag T and Richter
W: Effect of proteases and other treatments on the proliferative
assembly of tight junction strands in the rat prostate tissue. Exp
Pathol. 34:237–244. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kachar B and Reese TS: Evidence for the
lipidic nature of tight junction strands. Nature. 296:464–466.
1982. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kachar B and Reese TS: Formation of
misplaced and reflexive tight junction strands in prostate
epithelial cells. J Ultrastruct Res. 82:90–95. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kachar B and Pinto da Silva P: Rapid
massive assembly of tight junction strands. Science. 213:541–544.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martin TA, Das T, Mansel RE and Jiang WG:
Enhanced tight junction function in human breast cancer cells by
antioxidant, selenium and polyunsaturated lipid. J Cell Biochem.
101:155–166. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang WG, Martin TA, Matsumoto K, Nakamura
T and Mansel RE: Hepatocyte growth factor/scatter factor decreases
the expression of occludin and transendothelial resistance (TER)
and increases paracellular permeability in human vascular
endothelial cells. J Cell Physiol. 181:319–329. 1999. View Article : Google Scholar
|
|
26
|
Rosen EM, Zitnik RJ, Elias JA, Bhargava
MM, Wines J and Goldberg ID: The interaction of HGF-SF with other
cytokines in tumor invasion and angiogenesis. EXS. 65:301–310.
1993.PubMed/NCBI
|
|
27
|
Martin TA and Jiang WG: Tight junctions
and their role in cancer metastasis. Histol Histopathol.
16:1183–1195. 2001.PubMed/NCBI
|
|
28
|
Hurle RA, Davies G, Parr C, Mason MD,
Jenkins SA, Kynaston HG and Jiang WG: Hepatocyte growth
factor/scatter factor and prostate cancer: a review. Histol
Histopathol. 20:1339–1349. 2005.PubMed/NCBI
|
|
29
|
Davies G, Jiang WG and Mason MD:
Matrilysin mediates extracellular cleavage of E-cadherin from
prostate cancer cells: a key mechanism in hepatocyte growth
factor/scatter factor-induced cell-cell dissociation and in vitro
invasion. Clin Cancer Res. 7:3289–3297. 2001.
|
|
30
|
Jin M, Barron E, He S, Ryan SJ and Hinton
DR: Regulation of RPE intercellular junction integrity and function
by hepatocyte growth factor. Invest Ophthalmol Vis Sci.
43:2782–2790. 2002.PubMed/NCBI
|
|
31
|
Catizone A, Ricci G and Galdieri M:
Hepatocyte growth factor modulates Sertoli-Sertoli tight junction
dynamics. J Cell Physiol. 216:253–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grisendi S, Arpin M and Crepaldi T: Effect
of hepatocyte growth factor on assembly of zonula occludens-1
protein at the plasma membrane. J Cell Physiol. 176:465–471. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hollande F, Blanc EM, Bali JP, Whitehead
RH, Pelegrin A, Baldwin GS and Choquet A: HGF regulates tight
junctions in new nontumorigenic gastric epithelial cell line. Am J
Physiol Gastrointest Liver Physiol. 280:G910–G921. 2001.PubMed/NCBI
|
|
34
|
Nusrat A, Parkos CA, Bacarra AE, Godowski
PJ, Delp-Archer C, Rosen EM and Madara JL: Hepatocyte growth
factor/scatter factor effects on epithelia. Regulation of
intercellular junctions in transformed and nontransformed cell
lines, basolateral polarization of c-met receptor in transformed
and natural intestinal epithelia, and induction of rapid wound
repair in a transformed model epithelium. J Clin Invest.
93:2056–2065. 1994.
|
|
35
|
Shen BQ, Panos RJ, Hansen-Guzmán K,
Widdicombe JH and Mrsny RJ: Hepatocyte growth factor stimulates the
differentiation of human tracheal epithelia in vitro. Am J Physiol.
272:L1115–L1120. 1997.PubMed/NCBI
|
|
36
|
Date I, Takagi N, Takagi K, Tanonaka K,
Funakoshi H, Matsumoto K, Nakamura T and Takeo S: Hepatocyte growth
factor attenuates cerebral ischemia-induced increase in
permeability of the blood-brain barrier and decreases in expression
of tight junctional proteins in cerebral vessels. Neurosci Lett.
407:141–145. 2006. View Article : Google Scholar
|
|
37
|
Grant-Tschudy KS and Wira CR: Hepatocyte
growth factor regulation of uterine epithelial cell transepithelial
resistance and tumor necrosis factor alpha release in culture. Biol
Reprod. 72:814–821. 2005. View Article : Google Scholar
|
|
38
|
Liu F, Schaphorst KL, Verin AD, Jacobs K,
Birukova A, Day RM, Bogatcheva N, Bottaro DP and Garcia JG:
Hepatocyte growth factor enhances endothelial cell barrier function
and cortical cytoskeletal rearrangement: potential role of glycogen
synthase kinase-3beta. FASEB J. 16:950–962. 2002. View Article : Google Scholar
|
|
39
|
Fanning AS, Mitic LL and Anderson JM:
Transmembrane proteins in the tight junction barrier. J Am Soc
Nephrol. 10:1337–1345. 1999.PubMed/NCBI
|
|
40
|
Farshori P and Kachar B: Redistribution
and phosphorylation of occludin during opening and resealing of
tight junctions in cultured epithelial cells. J Membr Biol.
170:147–156. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wong V: Phosphorylation of occludin
correlates with occludin localization and function at the tight
junction. Am J Physiol. 273:C1859–C1867. 1997.PubMed/NCBI
|
|
42
|
Morita K, Furuse M, Fujimoto K and Tsukita
S: Claudin multigene family encoding four-transmembrane domain
protein components of tight junction strands. Proc Natl Acad Sci
USA. 96:511–516. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Busch C, Hanssen TA, Wagener C and OBrink
B: Down-regulation of CEACAM1 in human prostate cancer: correlation
with loss of cell polarity, increased proliferation rate, and
Gleason grade 3 to 4 transition. Hum Pathol. 33:290–298. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shin DY, Lee WS, Jung JH, et al:
Flavonoids from Orostachys japonicus A. Berger inhibit the
invasion of LNCaP prostate carcinoma cells by inactivating Akt and
modulating tight junctions. Int J Mol Sci. 14:18407–18420.
2013.PubMed/NCBI
|
|
45
|
Meng J, Mostaghel EA, Vakar-Lopez F,
Montgomery B, True L and Nelson PS: Testosterone regulates tight
junction proteins and influences prostatic autoimmune responses.
Horm Cancer. 2:145–156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maeda T, Murata M, Chiba H, Takasawa A,
Tanaka S, Kojima T, Masumori N, Tsukamoto T and Sawada N:
Claudin-4-targeted therapy using Clostridium perfringens
enterotoxin for prostate cancer. Prostate. 72:351–360. 2012.
View Article : Google Scholar
|
|
47
|
Nishida S, Hirohashi Y, Torigoe T, Inoue
R, Kitamura H, Tanaka T, Takahashi A, Asanuma H, Masumori N,
Tsukamoto T and Sato N: Prostate cancer stem-like
cells/cancer-initiating cells have an autocrine system of
hepatocyte growth factor. Cancer Sci. 104:431–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
van Leenders GJ, Sookhlall R, Teubel WJ,
de Ridder CM, Reneman S, Sacchetti A, Vissers KJ, van Weerden W and
Jenster G: Activation of c-MET induces a stem-like phenotype in
human prostate cancer. PLoS One. 6:e267532001.PubMed/NCBI
|
